Effect of treatment measures on clinical and laboratory indicators of patients with gingivitis in different course of the inflammatory process in the gums
DOI:
https://doi.org/10.11603/2311-9624.2020.4.11719Keywords:
chronic catarrhal gingivitis, the course of the inflammatory reaction, treatmentAbstract
Summary. To study the features of the inflammatory reaction in the gums, providing pathogenetic effects on periodontal tissues in the treatment and prevention scheme included drugs and hygiene products that reduce antigenic effects on periodontal tissues, sensitization, stimulate the body's adaptive mechanisms and regulate local inflammatory response.
The aim of the study – evaluation of the effectiveness of treatment measures for clinical and laboratory parameters of patients with gingivitis with different course of the inflammatory process in the gums.
Materials and Methods. To determine the course of the inflammatory process, the effectiveness of treatment and prevention of exacerbations of chronic catarrhal gingivitis 202 patients with chronic catarrhal gingivitis were taken for dispensary observation. After analysis of anamnestic data and the results of determining the phagocytic activity of leukocytes in the oral fluid of patients were divided into groups: main (102 people) and comparison (100 people); in the middle of the group by type of inflammatory reaction in the gums, patients were divided into hypo-, hyper- and normergic subgroups. All patients received basic therapy in accordance with the Protocol of medical care. In the main group for a month used pathogenetic agents – anti-inflammatory gel with neovitin, recommended hygiene products. In the comparison group for topical treatment used 3 % hydrogen peroxide solution, Holisal gel; for rinsing the mouth (during the first week of treatment) – "Rotokan", therapeutic and prophylactic toothpaste. Examinations and control examinations were performed to determine the hygienic condition of the oral cavity according to the hygienic index Green-Vermillion, GI the prevalence and intensity of the inflammatory process in the gums using Schiller-Pisarev test and PMA index, oral fluid (Ca and P content).
Results and Discussion. After treatment, patients in the main group had a decrease in the PMA index in the hypoergic subgroup by 2.6 times, hyperergic – by 3.5 times and normoergic – by 2.8 times; GI – 1.4 times, 1.4 times and 1.5 times (p <0.05), ONI-S – 3.9, 3.8 and 3.6 times (p <0.05), respectively. Six months later, the PMA index increased in all patients, but remained significantly lower than before treatment. The Schiller-Pisarev test after treatment and after 6 months in the main group was negative, without showing gum color, in the comparsson group after six months the test was from negative to weakly positive. The treatment contributed to an increase in the content of Ca in patients of the main group, and it did not differ significantly from the control indicator. Studies of oral fluid after 0.5 years showed that the content of Ca decreased, but did not reach pre-treatment; in the hypoergic group, this indicator differed significantly from the control indicator. A reduction in the duration of treatment was found – a smaller number of visits in the main group – 3.1, in the comparison group – 3.9 (p <0.05).
Conclusions. The results of clinical and laboratory studies showed that the use of the proposed therapy using neovitin gel contributed to better immediate treatment results: reduction of gingivitis in the PMA index by an average of 2.96 times (in the comparison group 2.16 times); reducing the number of doctor visits by 0.8. The content of Ca and P in different courses of the inflammatory reaction in the gums was lower in patients of the hypoergic subgroup. Topical treatment improved the oral fluid of patients, at the same time, six months after treatment in patients of the hypoergic subgroup, the content of Ca and P decreased, which probably requires the inclusion in the treatment scheme of the general effect on the body to increase reactivity.
References
Vernigorodskiy, V.S. (2004). Endotelialnaya disfunktsiya pri sakharnom diabete [Endothelial dysfunction in diabetes mellitus]. Vіsnyk Vіnnytskoho natsіonalnoho medychnoho unіversytetu – Bulletin of Vinnytsia National Medical University, 1, 86-87 [in Russian].
Kravchuk, N.O., & Aleksieieva, I.I. (2004). Doslidzhennia rivnia endotelinu-1 u khvorykh na tsukrovyi diabet II typu ta yoho korektsiia za dopomohoiu diabetonu MR [Study of endothelin-1 levels in patients with type II diabetes mellitus and its correction with MR diabetes mellitus]. Problemy endokrynnoi patolohii – Problems of Endocrine Pathology, 4, 3-7 [in Ukrainian].
Kalani, M. (2008). The importans of endothelin – 1 for microvascular dysfunction in diabetes. Vasc. Health Risk Manag., 4 (5), 1061-1068.
Zvershkhanovskiĭ, F.A., Zhulkevich, I.V., Danilishina, V.S., & Zhulkevich, G.D. (1987). Indicators of lipid metabolism and their relation to disorders of microcirculation in diabetes mellitus. Problemy Endokrinologii, 33 (4), 15-18.
Gomazkov, O.A. (2001). Endotelin v kardiologii: molekulyarnyye, fiziologicheskiye i patologicheskiye aspekty [Endothelin in cardiology: molecular, physiological and pathological aspects]. Kardiologiya – Cardiology, 2, 50-58 [in Russian].
Korkushko, O.V., & Lishnevskaya, V.Yu. (2003). Endotelialnaya disfunktsiya. Klinicheskiye aspekty, problemy [Endothelial dysfunction. Clinical aspects, problems]. Krovoobih i hemostaz – Blood Circulation and Hemostasis, 2, 4-15 [in Russian].
Malaya, L.T., & Korzh, A.N. (2000). Endotelialnaya disfunktsiya pri patologii serdechno-sosudistoy sistemy [Endothelial dysfunction in pathology of the cardiovascular system]. Kharkiv: Torsing [in Russian].
Sahach, V.F. (2008). Endotelin i sertsevo-sudynna systema [Endothelin and the cardiovascular system]. Fiziolohichnyi zhurnal – Physiological Journal, 44 (1-2), 103-109 [in Ukrainian].
Cai, H. (2000). Endothelial dysfunction in cardiovascular diseases – the role of oxidant stress. Circ. Res., 87, 840-844.
Zotova, I.V., Zatejshhikov, D.A., & Sidorenko, B.A. (2002). Sintez oksida azota i razvitie ateroskleroza. Kardiologiya – Cardiology., 4, 58-69 [in Russian].
Halcox, J. (2002). Endothelial dysfunction and prognosis circulation. Circulation, 106, 653-659.
Mohylnytska, L.M., & Mankovskyi, B.M. (2001). Endotelialna dysfunktsiia u khvorykh na tsukrovyi diabet 2 typu [Endothelial dysfunction in patients with type 2 diabetes]. Endokrynolohiia – Endocrinology, 6 (1), 95-106 [in Ukrainian].
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Clinical Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.